Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Third Harmonic Bio, Inc. ( (THRD) ) has issued an announcement.
On July 31, 2025, Third Harmonic Bio, Inc. filed a Form 25 with the SEC to voluntarily delist its common stock from Nasdaq, effective August 10, 2025, and plans to terminate its registration under the Exchange Act. This move is part of a broader Plan of Dissolution approved by the company’s board and stockholders, with a certificate of dissolution filed on the same date. The company has ceased recording stock transfers and set July 31, 2025, as the record date for determining stockholders eligible for future asset distributions. The dissolution process includes tax implications for both U.S. and Non-U.S. Holders, with potential capital gains or losses depending on individual circumstances.
The most recent analyst rating on (THRD) stock is a Hold with a $7.00 price target. To see the full list of analyst forecasts on Third Harmonic Bio, Inc. stock, see the THRD Stock Forecast page.
Spark’s Take on THRD Stock
According to Spark, TipRanks’ AI Analyst, THRD is a Neutral.
Third Harmonic Bio, Inc. has strong financial stability with high equity and low debt, but the lack of revenue and reliance on financing raise sustainability concerns. The technical analysis indicates a strong upward momentum, although overbought conditions suggest caution. The valuation is weak due to a negative P/E ratio and no dividend yield. Additionally, the recent restructuring plan underscores operational challenges and adds uncertainty to the company’s future prospects.
To see Spark’s full report on THRD stock, click here.
More about Third Harmonic Bio, Inc.
Average Trading Volume: 278,496
Technical Sentiment Signal: Sell
Current Market Cap: $243M
See more data about THRD stock on TipRanks’ Stock Analysis page.